Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort

Valentin Walker, Christine Perret-Guillaume, Emmanuelle Kesse-Guyot, Nelly Agrinier, Serge Hercberg, Pilar Galan, Karen E Assmann, Serge Briançon, Christine Rotonda, Valentin Walker, Christine Perret-Guillaume, Emmanuelle Kesse-Guyot, Nelly Agrinier, Serge Hercberg, Pilar Galan, Karen E Assmann, Serge Briançon, Christine Rotonda

Abstract

Introduction: Multimorbid chronic diseases are usually considered separately in trials. Here, we aimed to describe overall multimorbidity patterns in adults aged 55 years or older and assess their effect on health-related quality of life (HRQoL).

Methods: We used data for 5,647 participants included in the SUpplémentation en VItamines et Minéraux AntioXydants 2 (SU.VI.MAX 2) population-based trial. HRQoL was assessed by the French versions of the Medical Outcome Study Short Form 36 and the Duke Health Profile. An exploratory factor analysis was used to determine multimorbidity patterns, and a multimorbidity score for each resulting pattern was calculated. Adjusted multiple linear regression was used to examine the association between the identified multimorbidity and HRQoL scores by gender and for each age group (55-59, 60-64, 65-69, ≥ 70 years).

Results: More than 63% of the sample reported two or more chronic conditions (from 55.8% for those 55-59 years to 74.4% for those ≥ 70 years). Multimorbidity was more common among women than men (67.3% vs 60%). Two different multimorbidity patterns were identified. Pattern A was represented mainly by mental illness and bone impairments. Pattern B was represented mainly by cardiovascular and metabolic disorders. After adjusting for covariates, a high pattern A score was associated with reduced HRQoL for the physical and mental components of each HRQoL questionnaire, and a high pattern B score was associated with reduced HRQoL for only the physical component of each questionnaire. These multimorbidity scores affected HRQoL differently by age group.

Conclusion: Our study used a novel methodological approach to account for multimorbidity patterns in determining the link with chronic conditions. These multimorbidity scores (counted and weighted) can be used in clinical research to control for the effect of multimorbidity on patients' HRQoL and may be useful for clinical practice.

Clinical trial registration: Clinicaltrial.gov (number NCT00272428).

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Enrollment and flow of participants…
Fig 1. Enrollment and flow of participants in the Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) study and follow-up (SU.VI.MAX 2).
1 Doesn’t met eligibility criteria. 2 Under 55 years. 3 Missing data about sociodemographic characteristics, morbidities and quality of life.

References

    1. United Nations, Department of Economic and Social Affairs, Population Division [Internet]. 2015.
    1. Kirchberger I, Meisinger C, Heier M, Zimmermann A-K, Thorand B, Autenrieth CS, et al. Patterns of Multimorbidity in the Aged Population. Results from the KORA-Age Study. Thiem U, editor. PLoS ONE. 2012;7: e30556 10.1371/journal.pone.0030556
    1. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev. 2011;10: 430–439. 10.1016/j.arr.2011.03.003
    1. Van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51: 367–375.
    1. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54: 661–674.
    1. Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract. 2012;62: 821–826.
    1. Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of Multimorbidity and Morbidity Burden for Use in Primary Care and Community Settings: A Systematic Review and Guide. Ann Fam Med. 2012;10: 134–141. 10.1370/afm.1363
    1. Sprangers MA, de Regt EB, Andries F, van Agt HM, Bijl RV, de Boer JB, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000;53: 895–907.
    1. Guthrie B, Payne K, Alderson P, McMurdo MET, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345: e6341–e6341. 10.1136/bmj.e6341
    1. Garin N, Olaya B, Moneta MV, Miret M, Lobo A, Ayuso-Mateos JL, et al. Impact of Multimorbidity on Disability and Quality of Life in the Spanish Older Population. Glymour MM, editor. PLoS ONE. 2014;9: e111498 10.1371/journal.pone.0111498
    1. Lawson KD, Mercer SW, Wyke S, Grieve E, Guthrie B, Watt GC, et al. Double trouble: the impact of multimorbidity and deprivation on preference-weighted health related quality of life a cross sectional analysis of the Scottish Health Survey. Int J Equity Health. 2013;12: 67 10.1186/1475-9276-12-67
    1. Schäfer I, Hansen H, Schön G, Höfels S, Altiner A, Dahlhaus A, et al. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv Res. 2012;12: 89 10.1186/1472-6963-12-89
    1. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, Determinants and Patterns of Multimorbidity in Primary Care: A Systematic Review of Observational Studies. Scuteri A, editor. PLoS ONE. 2014;9: e102149 10.1371/journal.pone.0102149
    1. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. Jama. 2005;294: 716–724. 10.1001/jama.294.6.716
    1. Tinetti ME, Studenski SA. Comparative Effectiveness Research and Patients with Multiple Chronic Conditions. N ENGL J MED. 2011; 2478.
    1. Garin N, Olaya B, Perales J, Moneta MV, Miret M, Ayuso-Mateos JL, et al. Multimorbidity Patterns in a National Representative Sample of the Spanish Adult Population. Scuteri A, editor. PLoS ONE. 2014;9: e84794 10.1371/journal.pone.0084794
    1. Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M, et al. Global Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study. J Gerontol A Biol Sci Med Sci. 2016;71: 205–214. 10.1093/gerona/glv128
    1. Diaz E, Poblador-Pou B, Gimeno-Feliu L-A, Calderón-Larrañaga A, Kumar BN, Prados-Torres A. Multimorbidity and Its Patterns according to Immigrant Origin. A Nationwide Register-Based Study in Norway. Chamberlain AM, editor. PLOS ONE. 2015;10: e0145233 10.1371/journal.pone.0145233
    1. Clerencia-Sierra M, Calderón-Larrañaga A, Martínez-Velilla N, Vergara-Mitxeltorena I, Aldaz-Herce P, Poblador-Plou B, et al. Multimorbidity Patterns in Hospitalized Older Patients: Associations among Chronic Diseases and Geriatric Syndromes. PloS One. 2015;10: e0132909 10.1371/journal.pone.0132909
    1. Schäfer I, von Leitner E-C, Schön G, Koller D, Hansen H, Kolonko T, et al. Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions. Ross JS, editor. PLoS ONE. 2010;5: e15941 10.1371/journal.pone.0015941
    1. Hercberg S, Galan P, Preziosi P, Roussel AM, Arnaud J, Richard MJ, et al. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study. Int J Vitam Nutr Res Int Z Vitam- Ernahrungsforschung J Int Vitaminol Nutr. 1998;68: 3–20.
    1. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164: 2335–2342. 10.1001/archinte.164.21.2335
    1. Hercberg S, Kesse-Guyot E, Druesne-Pecollo N, Touvier M, Favier A, Latino-Martel P, et al. Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: A postintervention follow-up in the SU.VI.MAX Study. Int J Cancer. 2010;127: 1875–1881. 10.1002/ijc.25201
    1. Kesse-Guyot E, Fezeu L, Jeandel C, Ferry M, Andreeva V, Amieva H, et al. French adults’ cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. Am J Clin Nutr. 2011;94: 892–899. 10.3945/ajcn.110.007815
    1. L’étude SU.VI.MAX 2—Comportement alimentaire et qualité du vieillissement—Projet COMPALIMAGE [Internet].
    1. Leplège A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51: 1013–1023.
    1. Briancon S, Alla F, Mejat E, Guillemin F, Villemot J-P, Mertes P-M, et al. Mesure de l’incapacité fonctionnelle et de la qualité de vie dans l’insuffisance cardiaque. Adaptation transculturelle et validation des questionnaires de Goldman, du Minnesota et de Duke. Arch Mal Coeur Vaiss. 1997;90: 1577–1585.
    1. Kubinder K. On artificial results due to using factor analysis for dichotomous variables. Psychol Sci. 2003;45: 103–10.
    1. Cattell RB. The Scree Test For The Number Of Factors. Multivar Behav Res. 1966;1: 245–276.
    1. Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, Gimeno-Feliu LA, González-Rubio F, Poncel-Falcó A, et al. Multimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor Analysis. Gagnier JJ, editor. PLoS ONE. 2012;7: e32190 10.1371/journal.pone.0032190
    1. Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67: 254–266. 10.1016/j.jclinepi.2013.09.021
    1. Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJLM, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011;72: 341–348. 10.4088/JCP.10m06176blu
    1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. 12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004; 28–37. 10.1111/j.1600-0047.2004.00328.x
    1. He Y, Zhang M, Lin EHB, Bruffaerts R, Posada-Villa J, Angermeyer MC, et al. Mental disorders among persons with arthritis: results from the World Mental Health Surveys. Psychol Med. 2008;38: 1639 10.1017/S0033291707002474
    1. Campbell KE, Dennerstein L, Tacey M, Szoeke CE. The trajectory of negative mood and depressive symptoms over two decades. Maturitas. 2017;95: 36–41. 10.1016/j.maturitas.2016.10.011
    1. Swenson JR, Clinch JJ. Assessment of quality of life in patients with cardiac disease: the role of psychosomatic medicine. J Psychosom Res. 2000;48: 405–415.
    1. van Marwijk HWJ, van der Kooy KG, Stehouwer CDA, Beekman ATF, van Hout HPJ. Depression increases the onset of cardiovascular disease over and above other determinants in older primary care patients, a cohort study. BMC Cardiovasc Disord. 2015;15: 40 10.1186/s12872-015-0036-y
    1. Arokiasamy P, Uttamacharya U, Jain K, Biritwum RB, Yawson AE, Wu F, et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal? BMC Med. 2015;13: 178 10.1186/s12916-015-0402-8
    1. Hunger M, Thorand B, Schunk M, Döring A, Menn P, Peters A, et al. Multimorbidity and health-related quality of life in the older population: results from the German KORA-Age study. Health Qual Life Outcomes. 2011;9: 53 10.1186/1477-7525-9-53
    1. Wang R, Yan Z, Liang Y, Tan EC, Cai C, Jiang H, et al. Prevalence and Patterns of Chronic Disease Pairs and Multimorbidity among Older Chinese Adults Living in a Rural Area. PloS One. 2015;10: e0138521 10.1371/journal.pone.0138521
    1. Roberts KC, Rao DP, Bennett TL, Loukine L, Jayaraman GC. Prevalence and patterns of chronic disease multimorbidity and associated determinants in Canada. Health Promot Chronic Dis Prev Can Res Policy Pract. 2015;35: 87–94.
    1. Whitson HE, Johnson KS, Sloane R, Cigolle CT, Pieper CF, Landerman L, et al. Identifying Patterns of Multimorbidity in Older Americans: Application of Latent Class Analysis. J Am Geriatr Soc. 2016;64: 1668–1673. 10.1111/jgs.14201
    1. Hudon C, Fortin M, Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol. 2005;58: 603–608. 10.1016/j.jclinepi.2004.10.017
    1. Parkerson GR Jr, Broadhead E, Tse C-KJ. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. J Clin Epidemiol. 1993;46: 379–393.
    1. Diederichs C, Berger K, Bartels DB. The Measurement of Multiple Chronic Diseases—A Systematic Review on Existing Multimorbidity Indices. J Gerontol A Biol Sci Med Sci. 2011;66A: 301–311.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する